Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Movement disorders

Friedreich ataxia today—preparing for the final battle

Nature Reviews Neurology volume 11, pages 188–190 (2015)Cite this article

Subjects

Research into Friedreich ataxia has been hampered by low availability of study participants. Now, a European consortium has released baseline data from a continuing study of 592 patients with Friedreich ataxia, providing information on clinical features and progression. Such large cooperative studies might herald the final battle against this disabling disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Consequences of the GAA repeat expansion.

References

  1. Campuzano, V. et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423–1427 (1996).

    Article  CAS  Google Scholar 

  2. Reetz, K. et al. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol. 14, 174–182 (2015).

    Article  Google Scholar 

  3. Schmucker, S. & Puccio, H. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches. Hum. Mol. Genet. 19, R103–R110 (2010).

    Article  CAS  Google Scholar 

  4. Saccà, F. et al. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design. PLoS ONE 6, e17627 (2011).

    Article  Google Scholar 

  5. Filla, A. et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 59, 554–560 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Dürr, A. et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335, 1169–1175 (1996).

    Article  Google Scholar 

  7. Pandolfo, M. et al. Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Ann. Neurol. 76, 509–521 (2014).

    Article  CAS  Google Scholar 

  8. Parkinson, M. H., Schulz, J. B. & Giunti, P. Co-enzyme Q10 and idebenone use in Friedreich's ataxia. J. Neurochem. 126 (Suppl. 1), 125–141 (2013).

    Article  CAS  Google Scholar 

  9. Soragni, E. et al. Epigenetic therapy for Friedreich ataxia. Ann. Neurol. 76, 489–508 (2014).

    Article  CAS  Google Scholar 

  10. Plasterer, H. L. et al. Development of frataxin gene expression measures for the evaluation of experimental treatments in Friedreich's ataxia. PLoS ONE 8, e63958 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Josh Williams for checking the English in the article.

Author information

Authors and Affiliations

  1. Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche, Università di Napoli Federico II, Via Pansini 5, Napoli, I-80131, Italy

    Giuseppe De Michele & Alessandro Filla

Authors
  1. Giuseppe De Michele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Filla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe De Michele.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Michele, G., Filla, A. Friedreich ataxia today—preparing for the final battle. Nat Rev Neurol 11, 188–190 (2015). https://doi.org/10.1038/nrneurol.2015.33

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2015.33

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing